Léčivé přípravky s obsahem účinné látky Alektinib
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| S2026/00659/00 | 07. 07. 2026 | ROCHE s.r.o. | 19 550 294,40 | 17 455 620,00 | 19 550 294,40 | 17 455 620,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| S2026/00659/00 | S2026_00659_00_KS_Alektinib_anonym.pdf | Smlouva | 09. 07. 2026 11:25 | Dokument není zavirovaný |
List of Participants
| Show detail | |||||||
|---|---|---|---|---|---|---|---|
| ROCHE s.r.o. | Praha 8-Karlín | 19 550 294,40 | 17 455 620,00 | CZK | Yes | Yes |
Written Report - Justification
| Show detail | Justification for using other means of communication for submitting bids instead of electronic means | Justification for not dividing an above-threshold public procurement into lots | Justification for setting requirements for proving turnover in case of proceeding according to Article 78(3), if not stated in the tender documentation |
|---|---|---|---|
| Předmět VZ rozdělení neumožňuje. | Nebylo požadováno. |